Cargando…

Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration

BACKGROUND: Previous research has described distinct subtypes of Alzheimer’s disease (AD) based on the differences in regional patterns of brain atrophy on MRI. We conducted a data-driven exploration of distinct AD neurodegeneration subtypes using FDG-PET as a sensitive molecular imaging marker of n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levin, Fedor, Ferreira, Daniel, Lange, Catharina, Dyrba, Martin, Westman, Eric, Buchert, Ralph, Teipel, Stefan J., Grothe, Michel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896407/ https://www.ncbi.nlm.nih.gov/pubmed/33608059 http://dx.doi.org/10.1186/s13195-021-00785-9

Ejemplares similares

Association of PET‐based stages of amyloid deposition with neuropathological markers of Aβ pathology
por: Teipel, Stefan J., et al.
Publicado: (2020)

Mean diffusivity in cortical gray matter in Alzheimer's disease: The importance of partial volume correction
por: Henf, Judith, et al.
Publicado: (2017)

Gaussian Graphical Models Reveal Inter-Modal and Inter-Regional Conditional Dependencies of Brain Alterations in Alzheimer's Disease
por: Dyrba, Martin, et al.
Publicado: (2020)

Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease
por: Mohanty, Rosaleena, et al.
Publicado: (2022)

The cholinergic system in subtypes of Alzheimer’s disease: an in vivo longitudinal MRI study
por: Machado, Alejandra, et al.
Publicado: (2020)

Does Functional Connectivity Provide a Marker for Cognitive Rehabilitation Effects in Alzheimer’s Disease? An Interventional Study
por: Ochmann, Sina, et al.
Publicado: (2017)

In vivo staging of regional amyloid progression in healthy middle-aged to older people at risk of Alzheimer’s disease
por: Levin, Fedor, et al.
Publicado: (2021)

Comparison of subtyping methods for neuroimaging studies in Alzheimer’s disease: a call for harmonization
por: Mohanty, Rosaleena, et al.
Publicado: (2020)

In vivo staging of regional amyloid deposition
por: Grothe, Michel J., et al.
Publicado: (2017)

Is the left uncinate fasciculus associated with verbal fluency decline in mild Alzheimer's disease?
por: Kljajevic, Vanja, et al.
Publicado: (2016)

Longitudinal validity of PET‐based staging of regional amyloid deposition
por: Jelistratova, Irina, et al.
Publicado: (2020)

Multicenter stability of resting state fMRI in the detection of Alzheimer's disease and amnestic MCI
por: Teipel, Stefan J., et al.
Publicado: (2017)

Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [(18)F]FDG PET
por: Hellwig, Sabine, et al.
Publicado: (2018)

Evaluation of Multiple System Atrophy Subtypes with FDG-PET
por: Jellinger, Kurt
Publicado: (2021)

Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease
por: Teipel, Stefan J., et al.
Publicado: (2020)

Robust Detection of Impaired Resting State Functional Connectivity Networks in Alzheimer's Disease Using Elastic Net Regularized Regression
por: Teipel, Stefan J., et al.
Publicado: (2017)

Biological subtypes of Alzheimer disease: A systematic review and meta-analysis
por: Ferreira, Daniel, et al.
Publicado: (2020)

Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma
por: Maza, Sofiane, et al.
Publicado: (2013)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer’s disease
por: Ossenkoppele, Rik, et al.
Publicado: (2020)

FDG-PET assessment of the locus coeruleus in Alzheimer’s disease
por: Liu, Kathy Y., et al.
Publicado: (2021)

FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment — Beyond classical regression
por: Teipel, Stefan J., et al.
Publicado: (2015)

Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors
por: Teipel, Stefan J., et al.
Publicado: (2018)

[(18)F]FDG PET signal is driven by astroglial glutamate transport
por: Zimmer, Eduardo R., et al.
Publicado: (2017)

LATE: Nicht jede Demenz ist Alzheimer – Diskussion einer neuen Krankheitsentität am Fallbeispiel: Zum aktuellen Stand der „limbic-predominant age-related TDP-43 encephalopathy“ (LATE)
por: Görß, Doreen, et al.
Publicado: (2020)

(18)F-FDG-PET in Mouse Models of Alzheimer's Disease
por: Bouter, Caroline, et al.
Publicado: (2019)

Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology
por: Laforce, Robert, et al.
Publicado: (2014)

Subtypes of Alzheimer's Disease Display Distinct Network Abnormalities Extending Beyond Their Pattern of Brain Atrophy
por: Ferreira, Daniel, et al.
Publicado: (2019)

Selective neurodegeneration of the hippocampus caused by chronic cerebral hypoperfusion: F-18 FDG PET study in rats
por: Lee, Jung-In, et al.
Publicado: (2022)

FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Generative FDG-PET and MRI Model of Aging and Disease Progression in Alzheimer's Disease
por: Dukart, Juergen, et al.
Publicado: (2013)

Molecular properties underlying regional vulnerability to Alzheimer’s disease pathology
por: Grothe, Michel J, et al.
Publicado: (2018)

Partial Volume Correction Increases the Sensitivity of 18F-Florbetapir-Positron Emission Tomography for the Detection of Early Stage Amyloidosis
por: Teipel, Stefan J., et al.
Publicado: (2021)

Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET
por: Wiedenmann, Nicole, et al.
Publicado: (2018)

Patient‐related benefits of amyloid PET imaging in dementia: Rationale and design of the German randomized coverage with evidence development study ENABLE
por: Teipel, Stefan J., et al.
Publicado: (2023)

Study of the Influence of Age in (18)F-FDG PET Images Using a Data-Driven Approach and Its Evaluation in Alzheimer's Disease
por: Jiang, Jiehui, et al.
Publicado: (2018)

FDG-PET in colorectal cancer
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2006)

Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET
por: Wiedenmann, Nicole, et al.
Publicado: (2018)

Longitudinal [(18)F]FDG-PET/CT analysis of the glucose metabolism in ApoE-deficient mice
por: Kuhla, Angela, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_15of7hlpltpqvpttaf0sbrrns2